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OBJECTIVEdTo determine the correlates of the “metabolically healthy obese” (MHO) phe-
notype and the longitudinal risks of diabetes and cardiovascular disease (CVD)/stroke associated
with this phenotype.
RESEARCH DESIGN AND METHODSdThe North West Adelaide Health Study is a
prospective cohort study of 4,056 randomly selected adults aged$18 years. Participants free of
CVD/stroke and not underweight (n = 3,743) were stratiﬁed by BMI categories and metabolic
risk, deﬁned as having two or more International Diabetes Federation metabolic syndrome
criteria, excluding waist circumference.
RESULTSdCorrelates of the MHO (n = 454 [12.1%]) included smoking, socioeconomic
disadvantage, and physical inactivity. Compared with metabolically healthy normal-weight sub-
jects (n = 1,172 [31.3%]), theMHOweremore likely to developmetabolic risk (15.5 vs. 33.1%, P
, 0.001) and incident diabetes (odds ratio 2.09 [95% CI 0.87–5.03]) but not CVD/stroke (1.16
[0.58–2.29]) during 5.5–10.3 years of follow-up. These risks were not seen in MHO subjects
maintaining metabolic health (n = 188 [67%]). Sustained metabolic health in obese participants
was associated with age#40 years and lower waist circumference. Compared with the metabol-
ically at-risk obese, MHO women demonstrated a signiﬁcantly higher (mean [SE]) percentage of
leg fat (49.9 [0.5] vs. 53.2 [0.7]) and lower waist circumference (104 [0.6] vs. 101 cm [0.8]),
despite no signiﬁcant differences in overall adiposity.
CONCLUSIONSd“Healthy” obesity was a transient state for one-third of subjects. Persis-
tence of a MHO phenotype, which was associated with favorable outcomes, was related to
younger age and a more peripheral fat distribution. The MHO phenotype may be sustained by
promoting lower waist circumferences.
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G iven the scale of the obesity prob-lem, the notion of “healthy obesity”(1) requires evaluation to avoid
inappropriate public health messages.
The metabolically healthy obese (MHO)
phenotype, characterized by normal
metabolic parameters, such as serum cho-
lesterol andbloodpressure, despite elevated
BMI, has been reported in ;10–15% of
population samples, including the Fra-
mingham Offspring Study (2) and the
United States (3) and Korean (4) National
Health and Nutrition Examination Sur-
veys (NHANES). A review concluded
that the MHO demonstrated reduced
cardiovascular disease (CVD) risks com-
pared with metabolically at-risk obese
(MRO) subjects (5). However, the longi-
tudinal course of this phenotype is not
well described or understood, because
follow-up of the MHO phenotype has
occurred in few studies. Where follow-
up has occurred, there have been
conﬂicting results regarding mortality
outcomes (6–9).
Recent studies have reported that
within the metabolically healthy, obese
subjects demonstrated CVD risks (10,11)
similar to those of normal-weight sub-
jects. Some ﬁndings indicate that the
CVD risk attributable to obesity requires
the concomitant presence of metabolic
risk factors (6,12,13); however, Meigs
et al. (2) found that the MHO had a bor-
derline increased risk of developing diabe-
tes during an 11-year period. Outcomes
in the MHO may be related to differences
in body composition, ﬁtness, and inﬂam-
matory proﬁles. In a recent large study of
well-educated professional adults with
low baseline levels of obesity, the MHO
had better objectively assessed ﬁtness
than the MRO (6). Studies in small se-
lected samples of postmenopausal obese
women also suggest that the MHO may
havemore favorable inﬂammatory proﬁles
(14), less visceral fat, and possibly less he-
patic fat (15) than their counterparts with
insulin resistance and other metabolic ab-
normalities (16).
The aim of this study was to deter-
mine the correlates of the MHO and the
longitudinal outcomes of this phenotype
derived from a large cohort of adults. We
also examined diabetes and CVD out-
comes in relation to the stability of the
MHO over time, because previous stud-
ies have considered these phenotypes as
static populations, ignoring weight and
metabolic changes that occur over time.
In addition, we examined health-related
quality-of-life, body composition derived
from dual energy X-ray absorptiometry
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these phenotypes because previous stud-




Cohort participants and follow-up
The North West Adelaide Health Study
(NWAHS) is a representative biomedical
cohort study of adults of predominantly
mixed European descent, aged at least 18
years. The study methods (17) and their
validity to achieve an unbiased sample
have been described (18). From Decem-
ber 1999 to July 2003, 5,850 adults pro-
vided baseline survey data, of whom
4,056 underwent a biomedical examina-
tion (69.4% of those completing the ini-
tial interview). The present analysis was
conducted in 3,743 subjects free of exist-
ing CVD and not underweight at baseline.
The ﬁrst follow-up (stage 2) of the
cohort occurred between May 2004 and
February 2006, with the median follow-
up time being 4.0 years (range 1.7–5.8).
Survey data were obtained for 88% (n =
3,574) and clinic data for 79% (n =
3,206). DXA was conducted at stage 2,
involving 1,604 participants aged at least
50 years. The second follow-up (stage 3)
occurred between June 2008 and August
2010. Themedian follow-up time was 8.2
years (range 5.5–10.3), and survey data
were obtained for 67% (n = 2,710) and
clinic data for 61% (n = 2,487) of the orig-
inal clinic cohort. The same survey meth-
odologies were used at all stages of the
study.
Information was collected on demo-
graphics, doctor-diagnosed health condi-
tions (diabetes, myocardial infarction,
angina, stroke, transient ischemic attack),
behavioral risk factors, family history of
diabetes, the physical (PCS) and mental
component summary (MCS) scores of
the 36-item Short-Form (SF-36) health-
related quality-of-life assessment, and use
of therapies to lower lipid concentrations
and blood pressure. Clinic assessment
included measurement of height, weight,
waist circumference, and blood pressure,
and a fasting blood sample was drawn for
assessment of glucose and lipids. Diabetes
was identiﬁed by self-report of a doctor
diagnosis or fasting plasma glucose $7.0
mmol/L.
Classiﬁcation of metabolically at-risk
was deﬁned by having any two of the
following, consistent with the Inter-
national Diabetes Federation metabolic
syndrome criteria (19): triglyceride level
$1.7 mmol/L, HDL cholesterol level
,1.0 mmol/L in men or ,1.3 mmol/L
in women or lipid-lowering medication
use, blood pressure $130/85 mmHg or
antihypertensive medication use, and
fasting glucose level $5.6 mmol/L or
self-reported diabetes. Participants with
one risk factor or less were classiﬁed as
metabolically healthy. BMI was catego-
rized according to World Health Organi-
zation criteria (20). Subjects were then
classiﬁed according to their BMI as nor-
mal (18.5–24.9 kg/m2) or obese ($30.0
kg/m2) to identify metabolically healthy
normal-weight (MHNW), MHO, and
MRO phenotypes.
Recreational physical activity in the
previous 2 weeks was ascertained by
asking if the participant had engaged in
1) walking, and exercise that caused 2)
moderate or 3) large increases in heart
rate and breathing, as in vigorous activity.
A score was calculated as the frequency of
exercise sessions multiplied by the aver-
age time per session multiplied by (self-
perceived) intensity, where walking has
an intensity score of 3.5, moderate activ-
ity of 5, and vigorous activity of 7.5.
Scores of,100were classiﬁed as sedentary,
100–1,599 as low level, 1,600–3,199 or
$3,200 and ,2 h of vigorous exercise as
moderate, and $3,200 and $2 h of vig-
orous exercise as high. Thus, moderate ex-
ercise could equate to a minimum of 7.5 h
of walking per fortnight (17).
Sex-speciﬁc waist circumference cri-
teria (20) were used to classify abdominal
obesity as follows:mendnormal:,95 cm;
overweight: 95–101 cm; obese:$102 cm;
womendnormal: ,80 cm; overweight:
80–87 cm; obese: $88 cm.
Individual-level SES variables in-
cluded education level and household
income. The Socio-Economic Indexes
for Areas (SEIFA) Index of Relative Socio-
economicDisadvantage (IRSD) is ameasure
of area socioeconomic position produced
from the Australian Bureau of Statistics
Census data derived from area attributes
of percentages of people living with social
disadvantage (21).
Densitometry and body composition
A subanalysis assessing the relationship
between the phenotypes of interest and
body composition measures was conduc-
ted using DXA measures that were ob-
tained for 1,604 stage 2 participants aged
at least 50 years, of whom 758 women
and 588 men were free of CVD and not
underweight. The relationship between
phenotypes and grip strength was as-
sessed in all stage 2 clinic participants
(n = 3,206).
Scans were performed on a Prodigy
Dual Energy X-ray Absorptiometer, using
acquisition and analysis software Encore
version 9.15 (n = 1,259), or on a DPX+
Dual X-ray Absorptiometer using Lunar
DPX version 4.7e software (n = 348 pa-
tients; both machines GE Lunar, Madison,
WI). A system quality assurance test was
performed at the beginning of each scan
day to calibrate and verify correct opera-
tion of the scanner. In vitro precision for
whole-body scans performed on the Prod-
igy was estimated by scanning a whole
body phantom 10 times. The coefﬁcients
of variation were 0.48% for fat mass (FM)
and 0.44% for fat free mass (FFM). Total-
body bone density and body composition
data were collected on all subjects, with
acquisitions performed using the system-
recommended scan mode for patients
scanned on the Prodigy (thick or stan-
dard) and using the medium scan mode
for all subjects scanned on the DPX. Radi-
ation exposure to the region of interest
with either machine was approximately 1
mrem for each total-body scan. FM and
FFM were normalized for height by divid-
ing by height squared to generate the FM
index (FMI) and FFM index (FFMI) in
kilograms per meter squared to avoid
these measures being collinear with
height.
Grip strength (kg), which correlates
with lean mass, was available from all
stage 2 clinic participants and was mea-
sured three times with each hand using a
Jamar hand dynamometer (Lafayette In-
strument Company, Lafayette, IN) while
subjects were sitting with their arm sup-
ported by a horizontal surface. The best of
the six measurements was used to deﬁne
the maximum grip strength.
Statistical analysis
Data obtained were weighted to the Aus-
tralian Bureau of Statistics’ Census (22)
and Estimated Residential Population for
South Australia (23), by region, age
group, sex, and probability of selection
in the household, to provide population
representative estimates. Data were ana-
lyzed using SPSS 15.0 software (SPSS
Inc, Chicago, IL). Differences in propor-
tions were determined using the x2 test
and the Fisher exact test. Differences in
means were determined using ANOVA.
Variables signiﬁcant at P , 0.25 at the
univariate level were included in multi-
variable logistic regression analyses to
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identify correlates of the MHO phenotype
and the longitudinal associations with in-
cident diabetes and CVD/stroke events
adjusted for confounders. The ﬁnal
model assessing the association of MHO
with diabetes was adjusted for age, sex,
household income, and family history of
diabetes, with physical activity removed
in the ﬁnal model because it was not sig-
niﬁcant and the number with diabetes
was small (n = 112). The model for inci-
dent CVD/stroke was adjusted for age,
sex, smoking, household income, highest
education level and physical activity, and
LDL cholesterol. Multivariable ANOVA
determined mean differences in body
composition measures between groups
adjusted for age and smoking.
The ethics committees of the North
West Adelaide Health Service and the
University of Adelaide gave approval for
the conduct of the NWAHS, and all
subjects gave written, informed consent.
RESULTSdAt baseline, in 3,743 sub-
jects free of existing CVD and not un-
derweight, metabolic health was common
(66.8%, n = 2,499) and present in 88.3%
(n = 1,172) of normal-weight, 62.9% (n =
873) of overweight, and 44.2% (n = 454)
of obese subjects. The prevalence of two
or more cardiometabolic risk factors (de-
ﬁned as metabolically at-risk) was 33.2%
(n = 1,244) and present in 11.7% (n =
155) of normal-weight, 37.1% (n = 516)
of overweight, and 55.8% (n = 573) of
obese subjects.
Demographic and biomedical charac-
teristics of subjects classiﬁed as MHNW
(31.3%),MHO(12.1%), andMRO(15.3%)
are reported in Supplementary Table 1.
Sex was not signiﬁcantly related to obe-
sity within the metabolically healthy
subjects. Across the spectrum of health
from MHNW to MHO to MRO, there
were signiﬁcant increases in age, people
of lower SES, waist circumference, and
health service use and reductions in
smoking and physical activity. Despite
their metabolic health, MHO subjects
were signiﬁcantly more likely to report
poor to fair general health, as assessed
by the SF-36 Short Form 1 (SF-1),
and demonstrate signiﬁcantly reduced
(worse) SF-36 PCS and MCS scores com-
pared with the MHNW group adjusted
for age, sex, and smoking. However, the
MHOdemonstrated higher PCS andMCS
scores than MRO subjects.
In cross-sectional multivariable anal-
ysis at baseline (Table 1), compared with
the MHNW, the MHO phenotype was
signiﬁcantly associated with middle age,
neighborhood disadvantage, former
smoking, and low levels of physical ac-
tivity. An association with no alcohol
use approached signiﬁcance. However,
when compared with MRO subjects as
the reference population, consistent
with the analysis of NHANES 1999–
2004 data (3), the MHO were more likely
to be female (odds ratio [OR] 1.96 [95%
CI 1.56–2.44]), younger (age ,40 years:
4.58 [3.26–6.44]; age 40–54 years: 1.86
[1.35–2.56]), with lower levels of waist
circumference (normal: 3.20 [2.40–
4.25]; overweight: 2.33 [1.90–2.85]), be
engaging in moderate- to high-level phys-
ical activity (1.39 [1.10–1.76]), and resid-
ing in high SES neighborhoods (OR for
highest quintile of SEIFA-ID 1.52 [1.15–
2.01]; fourth quintile: 1.26 [0.98–1.63],
P = 0.07).
Longitudinal associations
Table 2 reports the stability of these phe-
notypes during the follow-up period. Par-
ticipants underwent changes in BMI
category and cardiometabolic risk, with
59% of the MHNW, 58% of MHO, and
71% of MRO subjects maintaining their
baseline status. Within those who were
Table 1dMultivariable logistic regression analyses of baseline biomedical and
demographic characteristics associated with obesity (MHO, n = 454) within
metabolically healthy subjects
MHO (%) OR (95% CI)
Sex
Female 14.4 1.00
Male 9.7 1.08 (0.79–1.46)
Age group (years)
#39 13.5 0.96 (0.56–1.64)
40–54 12.8 1.76 (1.02–3.05)
55–69 10.9 2.02 (1.13–3.60)
$70 6.4 1.00
Education level
Secondary school 13.0 1.21 (0.96–1.53)
Postsecondary 11.4 1.00
Household income
#$20,000/annum 11.4 1.11 (0.81–1.54)
.$20,000/annum 12.3 1.00
SEIFA IRSD quintile
Lowest 13.7 1.58 (1.11–2.25)
2nd 11.3 1.33 (0.89–1.98)
3rd 13.0 1.32 (0.93–1.89)




Former 12.7 1.41 (1.07–1.86)
Current 10.8 0.76 (0.57–1.02)
Physical activity
Sedentary 11.2 1.20 (0.87–1.64)
Low level 13.1 1.38 (1.04–1.82)
Moderate–high level 10.9 1.00
Alcohol risk
Nondrinkers, no risk 11.3 1.64 (0.96–2.82)
Low 13.7 1.56 (0.90–2.70)
Intermediate–very high 8.7 1.00
Diabetes family history
No 11.6 1.00
Yes 13.2 1.16 (0.91–1.48)
Primary care visits in previous year
,6 visits 12.0 1.00
$6 visits 12.4 1.25 (0.95–1.63)
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metabolically healthy at baseline, the de-
velopment of two or more cardiometa-
bolic risk factors was signiﬁcantly more
likely to occur in obese (baseline MHO,
33.1%, n = 93) compared with normal-
weight (MHNW, 15.5%, n = 99, P ,
0.001) subjects.
At follow-up,maintenance of baseline
metabolic health (#1 risk factor) oc-
curred in 67% (n = 188) of MHO partic-
ipants and was associated with the
following baseline variables: younger age
(,40 years, OR 8.38 [95% CI 2.13–
33.0]), lower levels of waist circum-
ference (OR per cm increase in waist
circumference 0.97 [0.95–0.99]), and
with low to middle quintiles of area-level
SES (2nd SEIFA IRSD quintile OR 2.34
[0.93–5.88], P = 0.07; 3rd SEIFA IRSD
quintile 2.72 [1.14–6.50] vs. lowest quin-
tile). No signiﬁcant association with mod-
erate to high levels of physical activity
(1.32 [0.69–2.52]), low/no risk alcohol
consumption (2.96 [0.77–11.4]), or
smoking behavior was observed. Physical
activity showed no association with main-
tenance of metabolic health when follow-
up physical activity was also considered
(data not shown).
Longitudinal risks of incident diabe-
tes and CVD/stroke in relation to baseline
MHO and MRO status are reported in Ta-
ble 3. The cumulative incidence rates of
diabetes and CVD/stroke events were 4.9
and 6.3%, respectively, in the overall
NWAHS population during the follow-up
period. Compared with the MHNW
group, MHO subjects demonstrated an in-
creased risk of developing diabetes border-
ing on signiﬁcance (OR 2.09, P = 0.09;
Table 3), but not CVD/stroke events, after
adjustment for confounders. In contrast,
the MRO were signiﬁcantly more likely to
develop diabetes and CVD/stroke events.
Given the instability of these pheno-
types over time, we assessed incident
events in relation to change in baseline
status for those classiﬁed as MHNW,
MHO, and MRO (Supplementary Table
2). In the MHO who remained stable over
time, incident diabetes (1.1%, n = 2) and
CVD/stroke cases (3.7%, n = 7) were un-
common and similar in frequency to those
who remained MHNW over time. In con-
trast, participants progressing from the
MHO to the MRO phenotype were signif-
icantly more likely to develop diabetes but
not CVD/stroke events. The burden of in-
cident events was borne largely by subjects
displaying a stable MRO phenotype; how-
ever, the burden was reduced in those
MRO who improved.
Table 4 reports the age- and smoking-
adjusted mean (SE) adiposity and lean
mass measures in MHNW, MHO, and
MRO participants. MHO women demon-
strated signiﬁcantly higher levels of per-
centage of leg fat and signiﬁcantly lower
levels of waist circumference, despite no
signiﬁcant differences in overall adiposity,
as measured by BMI, FMI, and percentage
of total fat, compared with MRO women.
MHO women also demonstrated a signif-
icantly lower FFMI, but no other differen-
ces in lean mass measures were observed
despite signiﬁcantly increased rates of
Table 2dCombined BMI (kg/m2) and metabolic risk factor status at follow-up in relation to baseline status
Follow-up at stage 3 (n = 2,315)a
Metabolically healthy Metabolically at risk
18.5–24.9 25.0–29.9 $30.0 18.5–24.9 25.0–29.9 $30.0
Baseline % (n) % (n) % (n) % (n) % (n) % (n)
Metabolically healthyb
BMI
18.5–24.9 (MHNW, n 5 636) 58.8 (374) 23.7 (151) 1.9 (12) 8.6 (55) 6.0 (38) 0.9 (6)
25.0–29.9 (n 5 566) 8.1 (46) 46.1 (261) 14.3 (81) 2.3 (13) 20.0 (113) 9.2 (52)
$30.0 (MHO, n 5 281) 0.4 (1) 8.9 (25) 57.7 (162) 0.0 (0) 2.5 (7) 30.6 (86)
Metabolically at riskc
BMI
18.5–24.9 (n 5 104) 28.8 (30) 9.6 (10) 0.0 (0) 40.4 (42) 19.2 (19) 1.9 (2)
25.0–29.9 (n 5 359) 3.6 (13) 17.3 (62) 2.5 (9) 4.2 (15) 55.4 (199) 17.0 (61)
$30.0 (MRO, n 5 369) 0.3 (1) 3.8 (14) 16.3 (60) 0.3 (1) 8.1 (30) 71.3 (369)
aStage 3 of the NWAHS occurred in 2008–2010. b#1 cardiometabolic risk factors according to International Diabetes Federation metabolic syndrome criteria, not
including waist circumference. c$2 cardiometabolic risk factors.
Table 3dAdjusted ORs and 95% CIs for incident diabetes and CVD/stroke in relation to
baseline BMI and metabolic risk statusa
Incident diabetes (n = 112) Incident CVD/stroke (n = 167)
Baseline % (n) ORb (95% CI) % (n) ORc (95% CI)
Metabolically healthy
BMI (kg/m2)
18.5–24.9 (MHNW) 1.7 (11) 1.00 (reference) 3.4 (25) 1.00 (reference)
25.0–29.9 1.7 (10) 0.88 (0.35–2.19) 5.2 (34) 1.17 (0.68–2.02)
$30.0 (MHO) 3.7 (11) 2.09 (0.87–5.03) 4.7 (15) 1.16 (0.58–2.29)
Metabolically at risk
BMI (kg/m2)
18.5–24.9 5.3 (5) 2.26 (0.68–7.52) 8.5 (10) 1.15 (0.50–2.62)
25.0–29.9 8.6 (29) 4.50 (2.08–9.73) 8.8 (36) 1.39 (0.79–2.42)
$30.0 (MRO) 14.3 (46) 7.79 (3.79–16.0) 10.7 (47) 2.23 (1.31–3.79)
aThe cumulative incidence rates of diabetes = 4.9% and CVD/stroke events = 6.3%. bAdjusted for age, sex,
household income, and family history of diabetes. cAdjusted for age, sex, smoking, household income,
highest education and physical activity, and LDL cholesterol.
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engaging in physical activity. In men, the
MHO demonstrated lower waist circum-
ferences than the MRO, but no signiﬁ-
cant differences in physical activity
levels or body composition measures
were observed.
CONCLUSIONSdIn our representa-
tive adult population, compared with
MHNW subjects, the MHO phenotype
was signiﬁcantly associated with disad-
vantaged SES, physical inactivity, and a
smoking historydfactors that expose
them to additional poor health outcomes.
We would argue that caution is warranted
when using the term “healthy obesity”
(24), because the relatively young MHO
demonstrated impaired health-related
quality-of-life and a signiﬁcant risk of
developing metabolic risk factors during
5 to 10 years of follow-up. The devel-
opment of cardiometabolic abnor-
malities in one-third of MHO subjects
conferred a signiﬁcantly increased risk of
diabetes.
The MHO phenotype was relatively
unstable over time, and this was an
important inﬂuence on cardiometabolic
outcomes for this group. When outcomes
were assessed in relation only to baseline
status, the MHO experienced elevated
but nonsigniﬁcant risks (P = 0.09) of
developing diabetes and no increased
CVD risk during our 5- to 10-year follow-
up period compared with MHNW sub-
jects. This is similar to previous studies
where metabolic change was not consid-
ered (2,6,12). The increased diabetes risk
that we observed was attributable to
those who progressed over time from
MHO to MRO. A novel ﬁnding of our
study is that longitudinally, youth and
lower central adiposity drove the mainte-
nance of metabolic health, and obese sub-
jects who maintained their metabolic
health experienced risks for diabetes
and CVD similar to MHNW subjects.
Thus, consistent with previous ﬁndings
in relation to CVD (12,13), the concom-
itant presence of metabolic risk factors
was associated with the development of
diabetes in our obese subjects.
Compared with obese adults with
metabolic abnormalities (MRO), the
MHO were younger, with less central
adiposity, a ﬁnding consistent with pre-
vious cross-sectional studies (3,7). The
MHO phenotype was also associated
with favorable social and behavioral fac-
tors, being characterized by younger age
(militating against CVD events), physical
activity, and being resident in high SES
neighborhoods, suggesting protection
by these factors in the context of socio-
economic advantage.
Exposure to potentially hazardous
adipokines and poor health behaviors in
the MHO may have played a role in the
switch in phenotype from MHO to MRO
in 32% of subjects, suggesting that many
MHO subjects are at an intermediate stage
of progression toward signiﬁcant meta-
bolic abnormalities and disease. There-
fore, targeted intervention opportunities
may exist for the maintenance of meta-
bolic health in younger people who are
obese without metabolic abnormalities
by promotion of healthier waist circum-
ferences.
The mechanisms underlying meta-
bolic health in obese subjects are unclear,
but the MHOmay be characterized by the
presence of less secretory adipose tissue
or reduced responsiveness to the effects of
adipokines (3). Our ﬁndings suggest the
possibility that fat distribution and, by in-
ference, the differences in adipocytokine
secretory properties of those fat depots
(25) may play an important role in the
outcomes associated with the MHO phe-
notypes. Further investigation of the po-
tential protective properties of increased
femoral-gluteal fat in the presence of re-
duced central fat inMHOwomen (despite
Table 4dMean (SE) adiposity and lean mass measures in relation to BMI (kg/m2) and
metabolic risk in men and women aged at least 50 years at stage 2 of the NWAHS
Normal weight (BMI 18.5–24.9) Obese (BMI $30.0)
MHNW MHO MRO
Females (n) 167 86 151
Age (years) 61.3 (0.7) 60.1 (0.8) 62.0 (0.7)
Adiposity measures
BMI 22.5 (0.1) 34.3 (0.5) 34.7 (0.3)
Waist circumference (cm) 77.5 (0.6) 101.1a (0.8) 104.0 (0.6)
FMI (kg/m2) 7.5 (0.2) 16.5 (0.2) 16.0 (0.2)
Percentage fat (%)
Total 32.9 (0.4) 47.8 (0.5) 46.5 (0.4)
Arm 33.8 (0.4) 48.9 (0.6) 48.4 (0.5)
Leg 38.7 (0.5) 53.2 (0.7)a 49.9 (0.5)
Lean mass measures
FFMI (kg/m2) 15.1 (0.1) 17.8 (0.1)a 18.3 (0.1)
Leg FFMI (kg/m2) 4.5 (0.04) 5.3 (0.05) 5.3 (0.04)
Grip strength (kg) 26.0 (0.4) 26.9 (0.6) 25.3 (0.5)
Physical activity, % (n)
Sedentary 24.8 (35) 31.3 (25) a 45.9 (61)
Low 33.3 (47) 43.8 (35) 38.3 (51)
Moderate–high 41.8 (59) 25.0 (20) 15.8 (21)
Males (n) 96 45 120
Age (years) 64.6 (1.1) 61.9 (1.5) 63.4 (0.7)
Adiposity measures
BMI 23.0 (0.2) 32.1 (0.3) 33.3 (0.3)
Waist circumference (cm) 88.4 (0.7) 110.7 (1.1)a 113.8 (0.7)
FMI (kg/m2) 5.0 (0.1) 11.2 (0.5) 11.1 (0.2)
Percentage fat (%)
Total 21.0 (0.5) 34.0 (0.7) 33.8 (0.4)
Arm 17.6 (0.6) 30.0 (0.9) 31.4 (0.5)
Leg 19.9 (0.6) 31.1 (0.8) 30.6 (0.5)
Lean mass measures
FFMI (kg/m2) 18.5 (0.1) 21.4 (0.2) 21.6 (0.2)
Leg FFMI (kg/m2) 5.7 (0.06) 6.5 (0.08) 6.5 (0.06)
Grip strength (kg) 42.4 (0.8) 41.7 (1.2) 42.0 (0.7)
Physical activity, % (n)
Sedentary 18.3 (15) 29.7 (11) 32.1 (34)
Low 36.6 (30) 32.4 (12) 34.0 (36)
Moderate–high 45.1 (37) 37.8 (14) 34.0 (36)
aP , 0.05 compared with MRO.
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similar total adiposity) is required given
that accumulation of fat peripherally in
the legs has been shown to be protective
against disturbed glucose metabolism
(26).MHOmen also demonstrated signif-
icantly lower levels of waist circumfer-
ence, but not increased leg fat, which
may be related to sexual dimorphism in
fat distribution (27). Studies in generally
small selected samples of obese adults re-
veal other important biochemical insights
into the MHO, including lower levels of
hepatic enzymes (15), ectopic fat (24), ca-
rotid intima-media thickness (24), insulin
disposition index (28), C-reactive protein
(16), and visceral fat accumulation (29),
as well as enhanced esteriﬁcation of fatty
acids into triglycerides and sequestration
of those triglycerides (30).
Studies suggest that the MHO are also
physically active (3,6). Ortega et al. (6)
recently demonstrated that the MHO
had better objectively assessed ﬁtness
and lower CVD mortality and morbidity
risks compared with the MRO in a large
cohort of high SES adults with low base-
line levels of obesity. The contribution of
social advantage to CVD outcomes (31)
was not considered by Ortega et al.
Cross-sectionally, metabolic health in
our obese subjects was also associated
with physical activity, albeit low-level ac-
tivity such as walking. However, mainte-
nance of MHO status was not related to
recreational physical activity at baseline
or follow-up, and contrary to our hypoth-
esis, lean mass and grip strength were not
greater inMHO compared withMROpar-
ticipants. The independent contributions
of strength and cardiorespiratory ﬁtness
to the development of metabolic risk
(32,33) and CVD (34) are unclear, and
the signiﬁcantly higher levels of lean/FFM
in our MROwomenmay represent inﬁltra-
tion of fatty tissue into skeletal muscle and
organs that cannot be discriminated as fat
by DXA. Given the conﬂicting evidence of
the hazards of diet-induced weight loss in
the MHO (35,36), physical activity has
been proposed as an intervention for
MHO individuals (37). Randomized con-
trolled trial evidence to support this is re-
quired, and these ﬁndings will have
signiﬁcant clinical implications for inter-
ventions to reduce obesity.
Variability in criteria to identify MHO
and differences in study sample popula-
tions make direct comparisons between
studies difﬁcult. The lack of an opera-
tional MHO deﬁnition is therefore a lim-
itation of all studies examining the
phenomenon of “healthy obesity,” and
an expert consensus to standardize the
identiﬁcation of MHO individuals is war-
ranted (14). Fewer NWAHS normal-
weight subjects were metabolically at
risk (12%) than the 23% reported by
Wildman et al. (3) using NHANES data.
The NWAHS did not measure two of six
NHANES risk factors (insulin sensitivity
and C-reactive protein) and might ac-
count for the lower levels of metabolic
abnormalities we reported.
There are limitations associated with
our study. This study reports ORs for
incident diabetes and CVD rather than
relative risks; however, the incidence of
these conditions in the population was
low and less than 10%, and in this case,
the OR closely approximates the relative
risk. When the equation of Zhang and Yu
(38) was used to correct the adjusted ORs
to better represent the relative risk, very
minor changes to the estimates reported
in Table 3 were observed (generally ﬁrst
decimal place increases or decreases), and
no changes were seen in the statistical sig-
niﬁcance of the associations. The number
of incident cases of diabetes (n = 112) and
CVD/stroke (n = 167) were small, as re-
ﬂected by the very wide CIs around the
ORs, and thus, our results should be in-
terpreted with caution.
Furthermore, the use of self-reported
CVD and physical activity might be
considered a limitation of this study. How-
ever, self-reports of cardiac and stroke
events have been reported to be accurate
(39,40), and the assessment of recreational
physical activity by self-report only, with-
out identiﬁcation of the type of activity
(endurance/resistance training), is similar
to other studies. Our survey was limited
to households with telephones, but be-
cause 97% of the households in the region
have telephones (18) and the demo-
graphic characteristics were representative
of the population of proﬁle of Adelaide
overall, the extent of any bias is likely to
be small.
The strengths of our study, however,
include our large randomly recruited re-
presentative population sample with bio-
medical and SES measures at several time
points, which permitted an examination
of the effects of change in metabolic status
on diabetes and CVD outcomes. To our
knowledge, this is the ﬁrst study to report
DXA-assessed body composition in the
MHO in a large representative sample of
older community-dwelling men and
women.
In conclusion, our data are consistent
with an MHO phenotype where younger
age and smaller waistlines may maintain
the metabolic health of this group over
time, and this state is associated with low
diabetes and CVD risks. A potential pro-
tective effect of peripheral fat distribution
against the development of metabolic
complications in metabolically healthy
but obese women requires further inves-
tigation. However, the MHO is temporary
for a sizeable proportion of obese adults;
thus, further longitudinal study of the
MHO phenotype is also important to
avoid inappropriate health messages
about the risks of obesity.
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